Diabetic Ketoacidosis and Acute Mountain Sickness: Case Report and Review of Treatment Options in Type 1 Diabetes Mellitus

被引:12
作者
Miller, Steven C. M. [1 ]
机构
[1] North Shore Hosp, Dept Endocrinol, Auckland 0629, New Zealand
关键词
diabetic ketoacidosis; DKA; acute mountain sickness; AMS; type 1 diabetes mellitus; T1DM; acetazolamide; dexamethasone; INSULIN SENSITIVITY; EXTREME ALTITUDE; EXPEDITION;
D O I
10.1016/j.wem.2014.09.033
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A 30-year-old man with a 20-year history of well-controlled type 1 diabetes mellitus and no microvascular complications traveled from near sea level to an altitude of 3000 m within 6 hours. At altitude, his blood glucose levels began to rise, necessitating increased insulin delivery. Typical symptoms of acute mountain sickness (AMS) developed, and he became increasingly hyperglycemic and unwell. Upon presentation to an emergency clinic, diabetic ketoacidosis (DKA) was diagnosed and was managed with insulin, intravenous fluids with potassium, and acetazolamide orally. No other potential causes for diabetic ketoacidosis were identified. Hyperglycemia, ketosis, and acidosis resolved with treatment as expected, but an increased insulin requirement was noted for the next 48 hours, until returning to expected levels when acetazolamide was discontinued. This case describes an episode of mild diabetic ketoacidosis potentially precipitated by moderate to severe acute mountain sickness, and an apparent hyperglycemic effect of acetazolamide. Individuals with type 1 diabetes traveling to altitude and their physicians should be vigilant for this complication and should be aware of the effects of conventional first-line therapies for acute mountain sickness on insulin requirement, glycemic control, and preexisting microvascular diabetes complications.
引用
收藏
页码:185 / 188
页数:4
相关论文
共 16 条
  • [1] [Anonymous], 2014, DIABETES CARE S, V37, P14
  • [2] Daniel B T, 2000, Crit Care Nurs Clin North Am, V12, P297
  • [3] Increased Insulin Requirements During Exercise at Very High Altitude in Type 1 Diabetes
    de Mol, Pieter
    de Vries, Suzanna T.
    de Koning, Eelco J. P.
    Gans, Rijk O. B.
    Tack, Cees J.
    Bilo, Henk J. G.
    [J]. DIABETES CARE, 2011, 34 (03) : 591 - 595
  • [4] Continuous Glucose Monitoring: Current Use and Future Directions
    DeSalvo, Daniel
    Buckingham, Bruce
    [J]. CURRENT DIABETES REPORTS, 2013, 13 (05) : 657 - 662
  • [5] Lack of gender difference in acetazolamide-induced cerebral vasomotor reactivity in patients suffering from type-1 diabetes mellitus
    Fülesdi, B
    Limburg, M
    Oláh, L
    Bereczki, D
    Csiba, L
    Kollár, J
    [J]. ACTA DIABETOLOGICA, 2001, 38 (03) : 107 - 112
  • [6] Going high with type 1 diabetes
    Leal, C
    [J]. HIGH ALTITUDE MEDICINE & BIOLOGY, 2005, 6 (01) : 14 - 21
  • [7] Wilderness Medical Society Consensus Guidelines for the Prevention and Treatment of Acute Altitude Illness
    Luks, Andrew M.
    McIntosh, Scott E.
    Grissom, Colin K.
    Auerbach, Paul S.
    Rodway, George W.
    Schoene, Robert B.
    Zafren, Ken
    Hackett, Peter H.
    [J]. WILDERNESS & ENVIRONMENTAL MEDICINE, 2010, 21 (02) : 146 - 155
  • [8] Extreme altitude mountaineering and Type 1 diabetes; the Diabetes Federation of Ireland Kilimanjaro Expedition
    Moore, K
    Vizzard, N
    Coleman, C
    McMahon, J
    Hayes, R
    Thompson, CJ
    [J]. DIABETIC MEDICINE, 2001, 18 (09) : 749 - 755
  • [9] Extreme altitude and mountaineering and type 1 diabetes - The Cho Oyu Alpinisti in Alta Quota Expedition
    Pavan, P
    Sarto, P
    Merlo, L
    Casara, D
    Ponchia, A
    Biasin, R
    Noventa, D
    Avogaro, A
    [J]. DIABETES CARE, 2003, 26 (11) : 3196 - 3197
  • [10] Management of diabetic ketoacidosis
    Savage, M. W.
    [J]. CLINICAL MEDICINE, 2011, 11 (02) : 154 - 156